Mobile Site ›
Print Page Email Page
Print Friendly View

Test ID: NMOC    
Neuromyelitis Optica (NMO) Autoantibody, IgG, Spinal Fluid

Secondary ID A test code used for billing and in test definitions created prior to November 2011

83936

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Establishing the diagnosis of neuromyelitis optica (NMO) and related disorders (eg, relapsing transverse myelitis or relapsing optic neuritis), predicting with 60% probability, relapse or progression to NMO in patients presenting with an initial episode of longitudinally extensive transverse myelitis. Seropositivity distinguishes these disorders from multiple sclerosis early in the course of disease. This allows initiation and maintenance of optimal therapy.

 

Serum is the preferred specimen for detection of NMO-IgG (see NMOER/60796 Neuromyelitis Optica (NMO) Evaluation with Reflex, Serum); cerebrospinal fluid is usually less informative.

Method Name A short description of the method used to perform the test

Indirect Immunofluorescence Assay (IFA)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

NMO-IgG, CSF

Aliases Lists additional common names for a test, as an aid in searching

AQP
AQP4
Aquaporin (-4)
Devic's Disease Antibody
Neuromyelitis Optica (NMO)
Optic Neuritix Antibody
Optic-Spinal MS Antibody
Vision Loss Antibody
Transverse Myelitis Antibody